Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qidan Yifei Tongqiao is a traditional Chinese medicine (TCM) prescription formulated as granules or decoction. It is primarily used for the treatment of allergic rhinitis and respiratory conditions. The mechanism of action involves regulating immune balance, specifically by modulating the Th17/Treg cell ratio, which plays a role in immune response and inflammation. Preclinical studies in rats have shown that it can relieve symptoms of allergic rhinitis by restoring Th17/Treg balance[1]. Clinical trials are ongoing to evaluate its efficacy in humans[2]. The formula consists of multiple herbal ingredients typical to TCM multi-herb prescriptions; however, specific constituent herbs are not detailed in the available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qidan Yifei Tongqiao.